These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

716 related articles for article (PubMed ID: 1963808)

  • 21. Tetrazepam: a benzodiazepine which dissociates sedation from other benzodiazepine activities. I. Psychopharmacological profile in rodents.
    Keane PE; Simiand J; Morre M; Biziere K
    J Pharmacol Exp Ther; 1988 May; 245(2):692-8. PubMed ID: 2896794
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tetrazepam: a benzodiazepine which dissociates sedation from other benzodiazepine activities. II. In vitro and in vivo interactions with benzodiazepine binding sites.
    Keane PE; Bachy A; Morre M; Biziere K
    J Pharmacol Exp Ther; 1988 May; 245(2):699-705. PubMed ID: 2896795
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Azirino[1, 2-d][1, 4]benzodiazepine derivatives and related 1,4-benzodiazepines as anticonvulsant agents in DBA/2 mice.
    De Sarro G; Chimirri A; Zappala M; Guisti P; Lipartiti M; De Sarro A
    Gen Pharmacol; 1996 Oct; 27(7):1155-62. PubMed ID: 8981061
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term studies on anticonvulsant tolerance and withdrawal characteristics of benzodiazepine receptor ligands in different seizure models in mice. I. Comparison of diazepam, clonazepam, clobazam and abecarnil.
    Löscher W; Rundfeldt C; Hönack D; Ebert U
    J Pharmacol Exp Ther; 1996 Nov; 279(2):561-72. PubMed ID: 8930158
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Behavioral and biochemical characterization of benzodiazepine receptor partial agonists in pigeons.
    Witkin JM; Acri JB; Wong G; Gleeson S; Barrett JE
    J Pharmacol Exp Ther; 1996 Apr; 277(1):87-96. PubMed ID: 8613971
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential contribution of GABA(A) receptor subtypes to the anticonvulsant efficacy of benzodiazepine site ligands.
    Fradley RL; Guscott MR; Bull S; Hallett DJ; Goodacre SC; Wafford KA; Garrett EM; Newman RJ; O'Meara GF; Whiting PJ; Rosahl TW; Dawson GR; Reynolds DS; Atack JR
    J Psychopharmacol; 2007 Jun; 21(4):384-91. PubMed ID: 17092983
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MDL 27,531 selectively reverses strychnine-induced seizures in mice.
    Kehne JH; Kane JM; Miller FP; Ketteler HJ; Braun DL; Senyah Y; Chaney SF; Abdallah A; Dudley MW; Ogden AM
    Br J Pharmacol; 1992 Aug; 106(4):910-6. PubMed ID: 1327393
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 5-ethoxymethyl-7-fluoro-3-oxo-1,2,3,5-tetrahydrobenzo[4,5]imidazo[1,2a]pyridine-4-N-(2-fluorophenyl)carboxamide (RWJ-51204), a new nonbenzodiazepine anxiolytic.
    Dubinsky B; Vaidya AH; Rosenthal DI; Hochman C; Crooke JJ; DeLuca S; DeVine A; Cheo-Isaacs CT; Carter AR; Jordan AD; Reitz AB; Shank RP
    J Pharmacol Exp Ther; 2002 Nov; 303(2):777-90. PubMed ID: 12388665
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacological studies on synthetic flavonoids: comparison with diazepam.
    Griebel G; Perrault G; Tan S; Schoemaker H; Sanger DJ
    Neuropharmacology; 1999 Jul; 38(7):965-77. PubMed ID: 10428415
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chronic treatment with diazepam or the inverse benzodiazepine receptor agonist FG 7142 causes differential changes in the effects of GABA receptor stimulation.
    Löscher W; Stephens DN
    Epilepsy Res; 1988; 2(4):253-9. PubMed ID: 2848700
    [TBL] [Abstract][Full Text] [Related]  

  • 31. TPA023 [7-(1,1-dimethylethyl)-6-(2-ethyl-2H-1,2,4-triazol-3-ylmethoxy)-3-(2-fluorophenyl)-1,2,4-triazolo[4,3-b]pyridazine], an agonist selective for alpha2- and alpha3-containing GABAA receptors, is a nonsedating anxiolytic in rodents and primates.
    Atack JR; Wafford KA; Tye SJ; Cook SM; Sohal B; Pike A; Sur C; Melillo D; Bristow L; Bromidge F; Ragan I; Kerby J; Street L; Carling R; Castro JL; Whiting P; Dawson GR; McKernan RM
    J Pharmacol Exp Ther; 2006 Jan; 316(1):410-22. PubMed ID: 16183706
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Demonstration of the partial agonist profiles of Ro 16-6028 and Ro 17-1812 in mice in vivo.
    Potier MC; Prado de Carvalho L; Venault P; Chapouthier G; Rossier J
    Eur J Pharmacol; 1988 Oct; 156(1):169-72. PubMed ID: 2850207
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhancement of GABA binding by the benzodiazepine partial agonist CGS9896.
    Meiners BA; Salama AI
    Eur J Pharmacol; 1985 Dec; 119(1-2):61-5. PubMed ID: 3002818
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacologic profile of a new anxiolytic, DN-2327: effect of Ro15-1788 and interaction with diazepam in rodents.
    Wada T; Fukuda N
    Psychopharmacology (Berl); 1991; 103(3):314-22. PubMed ID: 1676179
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Convulsions induced by submaximal dose of pentylenetetrazol in mice are antagonized by the benzodiazepine antagonist Ro 15-1788.
    Grecksch G; de Carvalho LP; Venault P; Chapouthier G; Rossier J
    Life Sci; 1983 May; 32(22):2579-84. PubMed ID: 6406779
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CGS 20625, a novel pyrazolopyridine anxiolytic.
    Williams M; Bennett DA; Loo PS; Braunwalder AF; Amrick CL; Wilson DE; Thompson TN; Schmutz M; Yokoyoma N; Wasley JW
    J Pharmacol Exp Ther; 1989 Jan; 248(1):89-96. PubMed ID: 2563294
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The pharmacological properties of Y-23684, a benzodiazepine receptor partial agonist.
    Yasumatsu H; Morimoto Y; Yamamoto Y; Takehara S; Fukuda T; Nakao T; Setoguchi M
    Br J Pharmacol; 1994 Apr; 111(4):1170-8. PubMed ID: 7913372
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reversal of benzodiazepine inverse agonist FG 7142-induced anxiety syndrome by neurosteroids in mice.
    Reddy DS; Kulkarni SK
    Methods Find Exp Clin Pharmacol; 1997 Dec; 19(10):665-81. PubMed ID: 9542718
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of neuroactive steroids on [3H]flumazenil binding to the GABAA receptor complex in vitro.
    Bertz RJ; Reynolds IJ; Kroboth PD
    Neuropharmacology; 1995 Sep; 34(9):1169-75. PubMed ID: 8532187
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacological evidence that PK 8165 behaves as a partial agonist of brain type benzodiazepine receptors.
    Mizoule J; Rataud J; Uzan A; Mazadier M; Daniel M; Gauthier A; Ollat C; Gueremy C; Renault C; Dubroeucq MC
    Arch Int Pharmacodyn Ther; 1984 Oct; 271(2):189-97. PubMed ID: 6095778
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.